Literature DB >> 24054956

Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.

Nasir Shariff1, Ravi V Desai, Kanan Patel, Mustafa I Ahmed, Gregg C Fonarow, Michael W Rich, Inmaculada B Aban, Maciej Banach, Thomas E Love, Michel White, Wilbert S Aronow, Andrew E Epstein, Ali Ahmed.   

Abstract

BACKGROUND: The prevalence of atrial fibrillation substantially increases after 70 years of age. However, the effect of rate-control versus rhythm-control strategies on outcomes in these patients remains unclear.
METHODS: In the randomized Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial, 4060 patients (mean age 70 years, range 49-80 years) with paroxysmal and persistent atrial fibrillation were randomized to rate-control versus rhythm-control strategies. Of these, 2248 were 70-80 years, of whom 1118 were in the rate-control group. Propensity scores for rate-control strategy were estimated for each of the 2248 patients and were used to assemble a cohort of 937 pairs of patients receiving rate-control versus rhythm-control strategies, balanced on 45 baseline characteristics.
RESULTS: Matched patients had a mean age of 75 years; 45% were women, 7% were nonwhite, and 47% had prior hospitalizations due to arrhythmias. During 3.4 years of mean follow-up, all-cause mortality occurred in 18% and 23% of matched patients in the rate-control and rhythm-control groups, respectively (hazard ratio [HR] associated with rate control, 0.77; 95% confidence interval [CI], 0.63-0.94; P = .010). HRs (95% CIs) for cardiovascular and noncardiovascular mortality associated with rate control were 0.88 (0.65-1.18) and 0.62 (0.46-0.84), respectively. All-cause hospitalization occurred in 61% and 68% of rate-control and rhythm-control patients, respectively (HR 0.76; 95% CI, 0.68-0.86). HRs (95% CIs) for cardiovascular and noncardiovascular hospitalization were 0.66 (0.56-0.77) and 1.07 (0.91-1.27), respectively.
CONCLUSION: In septuagenarian patients with atrial fibrillation, compared with rhythm-control, a rate-control strategy was associated with significantly lower mortality and hospitalization.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Hospitalization; Mortality; Older adults; Propensity score; Rate control; Rhythm control

Mesh:

Substances:

Year:  2013        PMID: 24054956      PMCID: PMC3818786          DOI: 10.1016/j.amjmed.2013.04.021

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.

Authors:  Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2011-11-25       Impact factor: 4.164

4.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

5.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

6.  Frequency of symptomatic atrial fibrillation in patients enrolled in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Andrew E Epstein; Humberto Vidaillet; H Leon Greene; Anne B Curtis; Kenneth A Ellenbogen; Todd Simmons; Mary Mickel
Journal:  J Cardiovasc Electrophysiol       Date:  2002-07

7.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Arch Intern Med       Date:  1987-09

8.  Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.

Authors:  Frederick A Masoudi; Edward P Havranek; Pam Wolfe; Cary P Gross; Saif S Rathore; John F Steiner; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

9.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Authors:  Jörg Carlsson; Sinisa Miketic; Jürgen Windeler; Alessandro Cuneo; Sebastian Haun; Stefan Micus; Sabine Walter; Ulrich Tebbe
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.

Authors:  Elizabeth S Kaufman; Paul A Zimmermann; Ted Wang; George W Dennish; Patrick D Barrell; Mary L Chandler; H Leon Greene
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

View more
  16 in total

1.  Emergency Department Readmission in Elderly Patients After Acute Rhythm or Rate Control Treatment for Atrial Fibrillation.

Authors:  Bonora Antonio; Turcato Gianni; Franchi Elena; Dilda Alice; Taioli Gabriele; Serafini Valentina; Sivero Valentina; Zannoni Massimo; Ricci Giorgio; Olivieri Oliviero
Journal:  J Atr Fibrillation       Date:  2016-08-31

2.  Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.

Authors:  Francesco Paciullo; Marco Proietti; Vanessa Bianconi; Alessandro Nobili; Matteo Pirro; Pier Mannuccio Mannucci; Gregory Y H Lip; Graziana Lupattelli
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

Review 3.  Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.

Authors:  Laurence Depoorter; Liza Sels; Mieke Deschodt; Bastiaan Van Grootven; Lorenz Van der Linden; Jos Tournoy
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

4.  Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study).

Authors:  Waqas Qureshi; Elsayed Z Soliman; Scott D Solomon; Alvaro Alonso; Dan E Arking; Amil Shah; Deepak K Gupta; Lynne E Wagenknecht; David Herrington
Journal:  Am J Cardiol       Date:  2014-08-18       Impact factor: 2.778

Review 5.  Cardioversion in Non-Valvular Atrial Fibrillation.

Authors:  Hermann H Klein; Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

6.  [Medicinal rate control in atrial fibrillation].

Authors:  Michael Näbauer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-02-15

7.  European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation.

Authors:  Cheng-Hung Li; Chia-Jen Liu; Annie Y Chou; Tze-Fan Chao; Ta-Chuan Tuan; Su-Jung Chen; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Fa-Po Chung; Jo-Nan Liao; Tzeng-Ji Chen; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

8.  Electrophysiology and heart rhythm disorders in older adults.

Authors:  Parag Goyal; Michael W Rich
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

Review 9.  Predisposing factors for atrial fibrillation in the elderly.

Authors:  Kristina Wasmer; Lars Eckardt; Günter Breithardt
Journal:  J Geriatr Cardiol       Date:  2017-03       Impact factor: 3.327

10.  Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium.

Authors:  Lu-Chen Weng; Kathryn L Lunetta; Martina Müller-Nurasyid; Albert Vernon Smith; Sébastien Thériault; Peter E Weeke; John Barnard; Joshua C Bis; Leo-Pekka Lyytikäinen; Marcus E Kleber; Andreas Martinsson; Henry J Lin; Michiel Rienstra; Stella Trompet; Bouwe P Krijthe; Marcus Dörr; Derek Klarin; Daniel I Chasman; Moritz F Sinner; Melanie Waldenberger; Lenore J Launer; Tamara B Harris; Elsayed Z Soliman; Alvaro Alonso; Guillaume Paré; Pedro L Teixeira; Joshua C Denny; M Benjamin Shoemaker; David R Van Wagoner; Jonathan D Smith; Bruce M Psaty; Nona Sotoodehnia; Kent D Taylor; Mika Kähönen; Kjell Nikus; Graciela E Delgado; Olle Melander; Gunnar Engström; Jie Yao; Xiuqing Guo; Ingrid E Christophersen; Patrick T Ellinor; Bastiaan Geelhoed; Niek Verweij; Peter Macfarlane; Ian Ford; Jan Heeringa; Oscar H Franco; André G Uitterlinden; Uwe Völker; Alexander Teumer; Lynda M Rose; Stefan Kääb; Vilmundur Gudnason; Dan E Arking; David Conen; Dan M Roden; Mina K Chung; Susan R Heckbert; Emelia J Benjamin; Terho Lehtimäki; Winfried März; J Gustav Smith; Jerome I Rotter; Pim van der Harst; J Wouter Jukema; Bruno H Stricker; Stephan B Felix; Christine M Albert; Steven A Lubitz
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.